Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Inflammatory Bowel Diseases

  Free Subscription

Articles published in Gastroenterology

Retrieve available abstracts of 298 articles:
HTML format

Single Articles

    November 2022
  1. LI Y, Pengbo S, Feng Y
    A new evaluation method for remission of ulcerative colitis.
    Gastroenterology. 2022 Nov 22:S0016-5085(22)01345.

  2. KUFTINEC GN, Lim JE, Yarur AJ
    A Rare but Devastating Dermatologic Manifestation of Ulcerative Colitis.
    Gastroenterology. 2022 Nov 3. pii: S0016-5085(22)01253.

  3. BALASUBRAMANIAM M, Nandi N, Aswani-Omprakash T, Sebastian S, et al
    Identifying Care Challenges as Opportunities for Research and Education in Inflammatory Bowel Disease in South Asia.
    Gastroenterology. 2022;163:1145-1150.

  4. GREEN PHR, Paski S, Ko CW, Rubio-Tapia A, et al
    AGA Clinical Practice Update on Management of Refractory Celiac Disease: Expert Review.
    Gastroenterology. 2022;163:1461-1469.
    PubMed     Abstract available

  5. DOLINGER MT, Dubinsky MC
    The Pediatric Inflammatory Crohn's Magnetic Resonance Enterography Index: A Step Forward for Transmural Pediatric Crohn's Disease Monitoring and Healing.
    Gastroenterology. 2022;163:1166-1167.

    Risankizumab for Induction and Maintenance of Remission in Crohn's Disease.
    Gastroenterology. 2022;163:1470-1471.

  7. FOCHT G, Cytter-Kuint R, Greer MC, Pratt LT, et al
    Development, Validation, and Evaluation of the Pediatric Inflammatory Crohn's Magnetic Resonance Enterography Index From the ImageKids Study.
    Gastroenterology. 2022;163:1306-1320.
    PubMed     Abstract available

  8. LEIBOVITZH H, Lee SH, Xue M, Raygoza Garay JA, et al
    Altered Gut Microbiome Composition and Function Are Associated With Gut Barrier Dysfunction in Healthy Relatives of Patients With Crohn's Disease.
    Gastroenterology. 2022;163:1364-1376.
    PubMed     Abstract available

  9. WU N, Hong SK, Huang WF
    Multiple Strictures of Small Intestine: Is It Crohn's Disease?
    Gastroenterology. 2022;163:e1-e2.

    October 2022
  10. WELZ L, Aden K
    Fibrosis and Inflammation in Inflammatory Bowel Disease-More Than 2 Sides of the Same Coin?
    Gastroenterology. 2022 Oct 29. pii: S0016-5085(22)01246.

  11. FORSS A, Ludvigsson JF, Olen O
    Letter to the Editor regarding "The Rising Burden of Inflammatory Bowel Disease in Denmark over Two Decades: A Nationwide Cohort Study" by Agrawal et al.
    Gastroenterology. 2022 Oct 21. pii: S0016-5085(22)01193.

    Microbial Riboflavin Biosynthesis Associates with Response to Dietary Fiber Consumption: Time to Personalize Adjunct Therapy in Patients with Inflammatory Bowel Disease?
    Gastroenterology. 2022 Oct 21. pii: S0016-5085(22)01194.

  13. PALMELA C, Maaser C
    The use of intestinal ultrasound in ulcerative colitis - more than a mucosal disease?
    Gastroenterology. 2022 Oct 9. pii: S0016-5085(22)01161.

  14. ALLEZ M
    A CEACAM5-derived Peptide Activating CD8(+) Regulatory T Cells: A Future Option for Restoring Mucosal Homeostasis in Crohn's Disease?
    Gastroenterology. 2022;163:822-824.

  15. SEGAL JP
    Ustekinumab Versus Adalimumab in Patients With Crohn's Disease.
    Gastroenterology. 2022;163:1115-1116.

  16. BRENNER TA, Steinway S
    Penile Necrosis in a Patient With Untreated Crohn's Disease.
    Gastroenterology. 2022;163:832-834.

  17. NGUYEN NH, Solitano V, Vuyyuru SK, MacDonald JK, et al
    Proactive Therapeutic Drug Monitoring Versus Conventional Management for Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis.
    Gastroenterology. 2022;163:937-949.
    PubMed     Abstract available

  18. GLOBIG AM, Mayer LS, Heeg M, Andrieux G, et al
    Exhaustion of CD39-Expressing CD8(+) T Cells in Crohn's Disease Is Linked to Clinical Outcome.
    Gastroenterology. 2022;163:965-981.
    PubMed     Abstract available

  19. DUNKIN D, Merlino F, Correale C, Yeretssian G, et al
    A Small CEACAM5 Peptide Restores the Protective Function of CD8(+) Regulatory T Cells in Crohn's Disease.
    Gastroenterology. 2022;163:1090-1093.

  20. GHIBOUB M, Penny S, Verburgt CM, Boneh RS, et al
    Metabolome Changes With Diet-Induced Remission in Pediatric Crohn's Disease.
    Gastroenterology. 2022;163:922-936.
    PubMed     Abstract available

    September 2022
  21. ARMSTRONG HK, Bording-Jorgensen M, Santer DM, Zhang Z, et al
    Unfermented beta-fructan fibers fuel inflammation in select inflammatory bowel disease patients.
    Gastroenterology. 2022 Sep 29. pii: S0016-5085(22)01150.
    PubMed     Abstract available

  22. UNGARO RC, Kappelman MD
    Reappraisal of COVID-19 Risk for Patients with Inflammatory Bowel Disease (IBD): Withdrawal of the British Society of Gastroenterology IBD Risk Grid.
    Gastroenterology. 2022 Sep 23. pii: S0016-5085(22)01069.

  23. D'AMICO F, Peyrin-Biroulet L, Danese S
    Is Selectivity the JAKpot Winner for Inflammatory Bowel Disease Treatment?
    Gastroenterology. 2022 Sep 22. pii: S0016-5085(22)01065.

  24. HUA X, Ungaro RC, Petrick LM, Chan AT, et al
    Inflammatory Bowel Disease is Associated with Prediagnostic Perturbances in Metabolic Pathways.
    Gastroenterology. 2022 Sep 16. pii: S0016-5085(22)01061.

  25. PEKOW J
    Fatigue in Inflammatory Bowel Disease: A Common Complaint With Few Answers.
    Gastroenterology. 2022 Sep 5. pii: S0016-5085(22)01032.

  26. TURPIN W, Dong M, Sasson G, Raygoza Garay JA, et al
    Mediterranean-Like Dietary Pattern Associations With Gut Microbiome Composition and Subclinical Gastrointestinal Inflammation.
    Gastroenterology. 2022;163:685-698.
    PubMed     Abstract available

  27. PIOVANI D, Hassan C, Repici A, Rimassa L, et al
    Risk of Cancer in Inflammatory Bowel Diseases: Umbrella Review and Reanalysis of Meta-analyses.
    Gastroenterology. 2022;163:671-684.
    PubMed     Abstract available

  28. MORTHA A, Remark R, Del Valle DM, Chuang LS, et al
    Neutralizing Anti-Granulocyte Macrophage-Colony Stimulating Factor Autoantibodies Recognize Post-Translational Glycosylations on Granulocyte Macrophage-Colony Stimulating Factor Years Before Diagnosis and Predict Complicated Crohn's Disease.
    Gastroenterology. 2022;163:659-670.
    PubMed     Abstract available

  29. LE COSQUER G, Zadro C, Gilletta C
    A Rare Pregnancy-related Complication of Crohn's Disease: Diagnosis and Treatment.
    Gastroenterology. 2022;163:586-587.

    August 2022
  30. DE VOOGD F, van Wassenaer EA, Mookhoek A, Bots S, et al
    Intestinal ultrasound is accurate to determine endoscopic response and remission in patients with moderate to severe ulcerative colitis: a longitudinal prospective cohort study.
    Gastroenterology. 2022 Aug 24. pii: S0016-5085(22)00966.
    PubMed     Abstract available

  31. CLEVELAND NK, Bressler B, Siegel CA
    A Summary of the BRIDGe Summit on Damage-Related Progression of Ulcerative Colitis: Establishing Research Priorities.
    Gastroenterology. 2022 Aug 11. pii: S0016-5085(22)00925.

  32. CHEN B, Zhong J, Li X, Pan F, et al
    Efficacy and Safety of Ivarmacitinib in Patients with Moderate-to-Severe, Active, Ulcerative Colitis: A Phase II Study.
    Gastroenterology. 2022 Aug 10. pii: S0016-5085(22)00918.
    PubMed     Abstract available

  33. BELLUSCI L, Zahra FT, Hopkins DE, Salazar JC, et al
    Durability of Immunity is low against SARS-CoV-2 Omicron BA.1, BA.2 and BA.3 variants following second and third vaccination in children and young adults with Inflammatory Bowel Disease receiving biologics.
    Gastroenterology. 2022 Aug 10. pii: S0016-5085(22)00920.

  34. AGRAWAL M, Christensen HS, Bogsted M, Colombel JF, et al
    The rising burden of inflammatory bowel disease in Denmark over two decades: a nationwide cohort study.
    Gastroenterology. 2022 Aug 8. pii: S0016-5085(22)00881.
    PubMed     Abstract available

  35. TRUYENS M, Lobaton T, Ferrante M, Bossuyt P, et al
    Effect of 5-hydroxytryptophan on fatigue in quiescent inflammatory bowel disease: a randomized controlled trial.
    Gastroenterology. 2022 Aug 5. pii: S0016-5085(22)00828.
    PubMed     Abstract available

  36. ZOLLNER A, Koch R, Jukic A, Pfister A, et al
    Postacute COVID-19 is Characterized by Gut Viral Antigen Persistence in Inflammatory Bowel Diseases.
    Gastroenterology. 2022;163:495-506.
    PubMed     Abstract available

    July 2022
  37. CROWLEY E, Griffiths AM, Jairath V
    Heterogeneity in Efficacy and Safety Endpoints for Pediatric Clinical Trials in Inflammatory Bowel Disease: A Need for Harmonization.
    Gastroenterology. 2022 Jul 15. pii: S0016-5085(22)00778.

  38. SPENCER EA, Dubinsky MC
    Failure to Achieve Target Drug Concentrations During Induction and Not HLA-DQA1*05 Carriage is Associated with Anti-Drug Antibody Formation in Patients with Inflammatory Bowel Disease: HLA-DQA1*05 Testing for Immunogenicity to anti-TNF Remains Relevan
    Gastroenterology. 2022 Jul 6. pii: S0016-5085(22)00748.

  39. WINE E
    Expanding Links Between Gut Microbiota and Bowel Inflammation.
    Gastroenterology. 2022;163:333-334.

  40. KUANG AG, Bahdi F, Shukla R
    Unusual Skin Ulcerations in a Patient With Hematochezia.
    Gastroenterology. 2022;163:e7-e9.

  41. MA C, Hanzel J, Panaccione R, Sandborn WJ, et al
    CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease.
    Gastroenterology. 2022 Jul 1. pii: S0016-5085(22)00730.
    PubMed     Abstract available

    June 2022
  42. HOUNTONDJI L, Rudler F, Blanc P
    An atypical cause of musculoskeletal pain in a patient with chronic inflammatory bowel disease.
    Gastroenterology. 2022 Jun 28. pii: S0016-5085(22)00727.

  43. MURAMOTO Y, Nihira H, Shiokawa M, Izawa K, et al
    Anti-integrin alphavbeta6 antibody as a diagnostic marker for pediatric patients with ulcerative colitis.
    Gastroenterology. 2022 Jun 13. pii: S0016-5085(22)00631.

  44. RICCIUTO A, Rauter I, McGovern DPB, Mader RM, et al
    Precision Medicine in Inflammatory Bowel Diseases: Challenges and Considerations for the Path Forward.
    Gastroenterology. 2022;162:1815-1821.

  45. DELSUPEHE AM, Bourgain C, Bossuyt P
    Subtle Trap for the Inflammatory Bowel Disease Endoscopy Central Reader.
    Gastroenterology. 2022;162:1849-1851.

  46. HANZEL J, Ma C, Jairath V
    Design of Clinical Trials for Mild to Moderate Crohn's Disease.
    Gastroenterology. 2022;162:1800-1814.

  47. LIU CY, Girish N, Gomez ML, Dube PE, et al
    Transitional Anal Cells Mediate Colonic Re-epithelialization in Colitis.
    Gastroenterology. 2022;162:1975-1989.
    PubMed     Abstract available

  48. D'HAENS GR, Sandborn WJ, Loftus EV Jr, Hanauer SB, et al
    Higher vs Standard Adalimumab Induction Dosing Regimens and Two Maintenance Strategies: Randomized SERENE CD Trial Results.
    Gastroenterology. 2022;162:1876-1890.
    PubMed     Abstract available

  49. ZHU Z, Gao Z, Li K
    Controversy of Preoperative Exposure to Tumor Necrosis Factor Inhibitors in Surgical and Infectious Complications of Inflammatory Bowel Disease.
    Gastroenterology. 2022 Jun 1. pii: S0016-5085(22)00588.

    May 2022
  50. TANG J, Wang JP, Chao K
    An Unusual Cause of Chronic Pancreatitis in a Patient with Crohn's Disease.
    Gastroenterology. 2022 May 18. pii: S0016-5085(22)00521.

  51. SABINO J
    Understanding the Role of PUFAs in Crohn's Disease.
    Gastroenterology. 2022;162:1590-1591.

  52. SANDBORN WJ, D'Haens GR, Reinisch W, Panes J, et al
    Guselkumab for the Treatment of Crohn's Disease: Induction Results From the Phase 2 GALAXI-1 Study.
    Gastroenterology. 2022;162:1650-1664.
    PubMed     Abstract available

  53. SHODA T, Collins MH, Rochman M, Wen T, et al
    Evaluating Eosinophilic Colitis as a Unique Disease Using Colonic Molecular Profiles: A Multi-Site Study.
    Gastroenterology. 2022;162:1635-1649.
    PubMed     Abstract available

  54. SCHWARZLER J, Mayr L, Vich Vila A, Grabherr F, et al
    PUFA-Induced Metabolic Enteritis as a Fuel for Crohn's Disease.
    Gastroenterology. 2022;162:1690-1704.
    PubMed     Abstract available

    April 2022
  55. CROSS RK, Keefer L
    Chicken or Egg, Mental Health Disorders in Inflammatory Bowel Disease: Does It Matter?
    Gastroenterology. 2022 Apr 29. pii: S0016-5085(22)00454.

  56. MA J, Wang Y, Cao H
    When neurology meets gastroenterology: an unusual case of ulcerative colitis.
    Gastroenterology. 2022 Apr 27. pii: S0016-5085(22)00447.

  57. WILSON A, Kim RB
    Correspondence: Failure to Achieve Target Drug Concentrations During Induction and Not HLA- DQA1*05 Carriage is Associated with Anti-Drug Antibody Formation in Patients with Inflammatory Bowel Disease - Is HLADQA1*05 gone before it's here?
    Gastroenterology. 2022 Apr 12. pii: S0016-5085(22)00367.

  58. COHEN BL, Fleshner P, Kane SV, Herfarth HH, et al
    Prospective Cohort Study to Investigate the Safety of Preoperative Tumor Necrosis Factor Inhibitor Exposure in Patients with Inflammatory Bowel Disease Undergoing Intra-abdominal Surgery.
    Gastroenterology. 2022 Apr 9. pii: S0016-5085(22)00359.

  59. IRVING PM, Gecse KB
    Optimizing Therapies Using Therapeutic Drug Monitoring: Current Strategies and Future Perspectives.
    Gastroenterology. 2022;162:1512-1524.
    PubMed     Abstract available

  60. PLEVRIS N, Lees CW
    Disease Monitoring in Inflammatory Bowel Disease: Evolving Principles and Possibilities.
    Gastroenterology. 2022;162:1456-1475.
    PubMed     Abstract available

  61. STIDHAM RW, Takenaka K
    Artificial Intelligence for Disease Assessment in Inflammatory Bowel Disease: How Will it Change Our Practice?
    Gastroenterology. 2022;162:1493-1506.
    PubMed     Abstract available

  62. VERSTOCKT B, Parkes M, Lee JC
    How Do We Predict a Patient's Disease Course and Whether They Will Respond to Specific Treatments?
    Gastroenterology. 2022;162:1383-1395.
    PubMed     Abstract available

  63. VERSTOCKT B, Bressler B, Martinez-Lozano H, McGovern D, et al
    Time to Revisit Disease Classification in Inflammatory Bowel Disease: Is the Current Classification of Inflammatory Bowel Disease Good Enough for Optimal Clinical Management?
    Gastroenterology. 2022;162:1370-1382.
    PubMed     Abstract available

  64. WILKENS R, Dolinger M, Burisch J, Maaser C, et al
    Point-of-Care Testing and Home Testing: Pragmatic Considerations for Widespread Incorporation of Stool Tests, Serum Tests, and Intestinal Ultrasound.
    Gastroenterology. 2022;162:1476-1492.
    PubMed     Abstract available

  65. LE BERRE C, Ricciuto A, Peyrin-Biroulet L, Turner D, et al
    Evolving Short- and Long-Term Goals of Management of Inflammatory Bowel Diseases: Getting It Right, Making It Last.
    Gastroenterology. 2022;162:1424-1438.
    PubMed     Abstract available

  66. KEEFER L, Bedell A, Norton C, Hart AL, et al
    How Should Pain, Fatigue, and Emotional Wellness Be Incorporated Into Treatment Goals for Optimal Management of Inflammatory Bowel Disease?
    Gastroenterology. 2022;162:1439-1451.
    PubMed     Abstract available

    March 2022
  67. VERSTOCKT S, Torres J, Verstockt B
    Gastroenterology. 2022 Mar 23. pii: S0016-5085(22)00289.

  68. FAIRBRASS KM, Gracie DJ, Ford AC
    Relative Contribution of Disease Activity and Psychological Health to Prognosis of Inflammatory Bowel Disease During 6.5 years of Longitudinal Follow-up.
    Gastroenterology. 2022 Mar 23. pii: S0016-5085(22)00265.
    PubMed     Abstract available

  69. REVES J, Chapman TP, Satsangi J, Torres J, et al
    Probing the Microbiome to Predict Response to Biologic Therapy in Inflammatory Bowel Disease-One Step Closer to Precision Medicine?
    Gastroenterology. 2022 Mar 23. pii: S0016-5085(22)00290.

  70. RABINOWITZ LG, Rabinowitz DG, Silver EM, Oxentenko AS, et al
    Disparities persist in inclusion of female, pregnant, lactating, and older individuals in inflammatory bowel disease clinical trials.
    Gastroenterology. 2022 Mar 11. pii: S0016-5085(22)00267.

  71. HAYASHI Y, Nakase H, Hisamatsu T
    Should we continue or discontinue inflammatory bowel disease medication in patients with COVID-19?
    Gastroenterology. 2022 Mar 11. pii: S0016-5085(22)00239.

  72. HU MD, Golovchenko NB, Burns GL, Nair PM, et al
    gammadelta Intraepithelial Lymphocytes Facilitate Pathological Epithelial Cell Shedding Via CD103-Mediated Granzyme Release.
    Gastroenterology. 2022;162:877-889.
    PubMed     Abstract available

  73. GOBERT AP, Latour YL, Asim M, Barry DP, et al
    Protective Role of Spermidine in Colitis and Colon Carcinogenesis.
    Gastroenterology. 2022;162:813-827.
    PubMed     Abstract available

    February 2022
  74. PANES J, Colombel JF, D'Haens GR, Schreiber S, et al
    Higher vs Standard Adalimumab Induction and Maintenance Dosing Regimens for Treatment of Ulcerative Colitis: SERENE UC Trial Results.
    Gastroenterology. 2022 Feb 25. pii: S0016-5085(22)00199.
    PubMed     Abstract available

  75. HART A, Rubin DT
    Entering the Era of Disease Modification in Inflammatory Bowel Disease.
    Gastroenterology. 2022 Feb 11. pii: S0016-5085(22)00141.

  76. ABRAHAM C, Abreu MT, Turner JR
    Pattern Recognition Receptor Signaling and Cytokine Networks in Microbial Defenses and Regulation of Intestinal Barriers: Implications for Inflammatory Bowel Disease.
    Gastroenterology. 2022 Feb 8. pii: S0016-5085(22)00125.
    PubMed     Abstract available

  77. KHANNA R, Chande N, Marshall JK
    Ozanimod for the Treatment of Ulcerative Colitis.
    Gastroenterology. 2022 Feb 2. pii: S0016-5085(22)00088.

  78. EDELMAN-KLAPPER H, Zittan E, Bar-Gil Shitrit A, Rabinowitz KM, et al
    Lower Serologic Response to COVID-19 mRNA Vaccine in Patients With Inflammatory Bowel Diseases Treated With Anti-TNFalpha.
    Gastroenterology. 2022;162:454-467.
    PubMed     Abstract available

  79. SANDS BE, Peyrin-Biroulet L, Kierkus J, Higgins PDR, et al
    Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Crohn's Disease.
    Gastroenterology. 2022;162:495-508.
    PubMed     Abstract available

  80. STADNIK A, Wojcicki M, Milkiewicz P
    Splenic Tumor in a Patient After Liver Transplantation.
    Gastroenterology. 2022;162:e14-e15.

    January 2022
  81. CLEVELAND NK, Torres J, Rubin DT
    Gastroenterology. 2022 Jan 28. pii: S0016-5085(22)00077.
    PubMed     Abstract available

  82. SPENCER EA, Stachelski J, Dervieux T, Dubinsky MC, et al
    Failure to Achieve Target Drug Concentrations During Induction and Not HLA-DQA1*05 Carriage is Associated with Anti-Drug Antibody Formation in Patients with Inflammatory Bowel Disease.
    Gastroenterology. 2022 Jan 10. pii: S0016-5085(22)00017.

  83. SEDANO R, Jairath V, Ma C, Sedano R, et al
    Design of clinical trials for mild-to-moderate ulcerative colitis.
    Gastroenterology. 2022 Jan 5. pii: S0016-5085(22)00004.

  84. PRATT M, Forbes JD, Knox NC, Van Domselaar G, et al
    Colorectal cancer screening in IBD - can characterization of GI microbiome signatures enhance neoplasia detection?
    Gastroenterology. 2022 Jan 5. pii: S0016-5085(22)00007.
    PubMed     Abstract available

  85. KUENZIG ME, Fung SG, Marderfeld L, Mak JW, et al
    Twenty-first century trends in the global epidemiology of pediatric-onset inflammatory bowel disease: systematic review.
    Gastroenterology. 2022 Jan 4. pii: S0016-5085(22)00002.
    PubMed     Abstract available

  86. LEVINE I, Swaminath A, Roitman I, Sultan K, et al
    COVID-19 Vaccination and Inflammatory Bowel Disease: Desired Antibody Responses, Future Directions, and a Note of Caution.
    Gastroenterology. 2022;162:349-350.

  87. SAKURABA A, Luna A, Micic D
    Serologic Response to Coronavirus Disease 2019 (COVID-19) Vaccination in Patients With Immune-Mediated Inflammatory Diseases: A Systematic Review and Meta-analysis.
    Gastroenterology. 2022;162:88-108.
    PubMed     Abstract available

  88. SEDANO R, Hogan M, Mcdonald C, Aswani-Omprakash T, et al
    Underrepresentation of Minorities and Underreporting of Race and Ethnicity in Crohn's Disease Clinical Trials.
    Gastroenterology. 2022;162:338-340.

  89. YANG W, Liu H, Xu L, Yu T, et al
    GPR120 Inhibits Colitis Through Regulation of CD4(+) T Cell Interleukin 10 Production.
    Gastroenterology. 2022;162:150-165.
    PubMed     Abstract available

  90. BECKER HEF, Penders J, Jonkers DMAE
    Microbial Metabolism of Inflammatory Bowel Disease Drugs: Current Evidence and Clinical Implementations.
    Gastroenterology. 2022;162:4-8.

  91. D'HAENS G, Rieder F, Feagan BG, Higgins PDR, et al
    Challenges in the Pathophysiology, Diagnosis, and Management of Intestinal Fibrosis in Inflammatory Bowel Disease.
    Gastroenterology. 2022;162:26-31.

  92. ALTEPETER T, Wertheimer E, Lee JJ
    Expediting Drug Development for Pediatric Inflammatory Bowel Disease: A Workshop to Identify Barriers and Move Forward.
    Gastroenterology. 2022;162:22-25.

    December 2021
  93. LAMB CA, Saifuddin A, Powell N, Rieder F, et al
    The future of precision medicine to predict outcomes and control tissue remodeling in inflammatory bowel disease.
    Gastroenterology. 2021 Dec 14. pii: S0016-5085(21)04069.
    PubMed     Abstract available

  94. TORRES J, Ungaro RC, Colombel JF
    Is prevention the best way to modify inflammatory bowel disease? How close are we?
    Gastroenterology. 2021 Dec 11. pii: S0016-5085(21)04071.

  95. D'AMICO F, Allocca M, Fiorino G
    Positioning ozanimod in ulcerative colitis: restoring leukocyte traffic under control.
    Gastroenterology. 2021 Dec 8. pii: S0016-5085(21)04063.

  96. DARGENIO VN, Cristofori F, Francavilla R
    An unexpected guest in a patient with ulcerative colitis.
    Gastroenterology. 2021 Dec 2. pii: S0016-5085(21)04041.

  97. FAYE AS, Dodson JA, Shaukat A
    Safety and Efficacy of Anti-TNF Therapy in Older Adults with Ulcerative Colitis: A New Path Forward.
    Gastroenterology. 2021 Dec 2. pii: S0016-5085(21)03816.

  98. SHEEHAN JL, Cohen-Mekelburg S
    Positioning infliximab and vedolizumab in the treatment of moderate-to-severe ulcerative colitis.
    Gastroenterology. 2021 Dec 2. pii: S0016-5085(21)03815.

  99. CHAPMAN TP, Reves J, Torres J, Satsangi J, et al
    Anti-SARS-CoV-2 Antibody Responses in Patients With IBD Treated With Biologics: Are We Finding CLARITY?
    Gastroenterology. 2021;161:2057-2059.

  100. GOLD SL, Cohen-Mekelburg S
    An Apple a Day Keeps the Doctor Away: The Effect of a Low-Fat, High-Fiber Diet on Quality of Life, Inflammation, and Dysbiosis in Patients with Ulcerative Colitis.
    Gastroenterology. 2021 Dec 1. pii: S0016-5085(21)03810.

  101. LI X, Liang D, Huang B
    Gastroenterology. 2021;161:2066-2067.

  102. ZHANG B, Zhang S
    The Potential of Radiomics in the Assessment of Intestinal Fibrosis in Crohn's Disease.
    Gastroenterology. 2021;161:2065-2066.

  103. KUO WT, Zuo L, Odenwald MA, Madha S, et al
    The Tight Junction Protein ZO-1 Is Dispensable for Barrier Function but Critical for Effective Mucosal Repair.
    Gastroenterology. 2021;161:1924-1939.
    PubMed     Abstract available

    November 2021
  104. DI NARZO AF, Houten SM, Kosoy R, Huang R, et al
    Integrative analysis of the Inflammatory Bowel Disease serum metabolome improves our understanding of genetic etiology and points to novel putative therapeutic targets.
    Gastroenterology. 2021 Nov 12. pii: S0016-5085(21)03738.
    PubMed     Abstract available

  105. BOLTON C, Smillie CS, Pandey S, Elmentaite R, et al
    An integrated taxonomy for monogenic inflammatory bowel disease.
    Gastroenterology. 2021 Nov 12. pii: S0016-5085(21)03737.
    PubMed     Abstract available

  106. CAO Y, Wang Z, Yan Y, Ji L, et al
    Enterotoxigenic Bacteroidesfragilis Promotes Intestinal Inflammation and Malignancy by Inhibiting Exosome-Packaged miR-149-3p.
    Gastroenterology. 2021;161:1552-1566.
    PubMed     Abstract available

  107. LEE SH, Turpin W, Espin-Garcia O, Raygoza Garay JA, et al
    Anti-Microbial Antibody Response is Associated With Future Onset of Crohn's Disease Independent of Biomarkers of Altered Gut Barrier Function, Subclinical Inflammation, and Genetic Risk.
    Gastroenterology. 2021;161:1540-1551.
    PubMed     Abstract available

    October 2021
  108. SHAH SC, Itzkowitz SH
    Colorectal Cancer in Inflammatory Bowel Disease: Mechanisms and Management.
    Gastroenterology. 2021 Oct 29. pii: S0016-5085(21)03707.

  109. BEN-HORIN S, Novack L, Mao R, Guo J, et al
    Efficacy of biologic drugs in short-duration versus long-duration inflammatory bowel disease: A systematic review and an individual-patient data meta-analysis of randomized controlled trials.
    Gastroenterology. 2021 Oct 29. pii: S0016-5085(21)03709.
    PubMed     Abstract available

  110. SPIERA E, Agrawal M, Ungaro R
    COVID-19 mRNA Vaccine Short-Term Safety in Patients with Inflammatory Bowel Disease.
    Gastroenterology. 2021 Oct 6. pii: S0016-5085(21)03619.

  111. KAPPELMAN MD, Weaver KN, Boccieri M, Firestine A, et al
    Humoral Immune Response to Messenger RNA COVID-19 Vaccines Among Patients With Inflammatory Bowel Disease.
    Gastroenterology. 2021;161:1340-1343.

  112. LIMA S, Gogokhia L, Viladomiu M, Chou L, et al
    Transferable IgA-coated Odoribacter splanchnicus in Responders to Fecal Microbiota Transplantation for Ulcerative Colitis Limits Colonic Inflammation.
    Gastroenterology. 2021 Oct 1. pii: S0016-5085(21)03610.
    PubMed     Abstract available

  113. SASSON SC, Slevin SM, Cheung VTF, Nassiri I, et al
    Interferon-Gamma-Producing CD8(+) Tissue Resident Memory T Cells Are a Targetable Hallmark of Immune Checkpoint Inhibitor-Colitis.
    Gastroenterology. 2021;161:1229-1244.
    PubMed     Abstract available

  114. XIAO L, Ma XX, Luo J, Chung HK, et al
    Circular RNA CircHIPK3 Promotes Homeostasis of the Intestinal Epithelium by Reducing MicroRNA 29b Function.
    Gastroenterology. 2021;161:1303-1317.
    PubMed     Abstract available

    September 2021
  115. CLEVELAND NK, Rai V, El Jurdi K, Rao SS, et al
    Gastroenterology. 2021 Sep 28. pii: S0016-5085(21)03564.

  116. SUGIMOTO S, Iwao Y, Shimoda M, Takabayashi K, et al
    Epithelium Replacement Contributes to Field Expansion of Squamous Epithelium and Ulcerative Colitis-Associated Neoplasia.
    Gastroenterology. 2021 Sep 28. pii: S0016-5085(21)03563.

  117. COHEN NA, Silfen A, Rubin DT
    Inclusion of Under-Represented Racial and Ethnic Minorities in Randomized Clinical Trials for Inflammatory Bowel Disease.
    Gastroenterology. 2021 Sep 22. pii: S0016-5085(21)03535.

  118. KHANNA R, Wilson AS, Gregor JC, Prowse KL, et al
    Clinical Guidelines for the Management of Inflammatory Bowel Disease.
    Gastroenterology. 2021 Sep 14. pii: S0016-5085(21)03521.

  119. PANES J
    Integrin inhibitors in inflammatory bowel disease: from therapeutic antibodies to small molecule drugs.
    Gastroenterology. 2021 Sep 13. pii: S0016-5085(21)03495.

  120. KONDO A, Ma S, Lee MYY, Ortiz V, et al
    Highly multiplexed image analysis of intestinal tissue sections in patients with inflammatory bowel disease.
    Gastroenterology. 2021 Sep 13. pii: S0016-5085(21)03480.
    PubMed     Abstract available

  121. UNGARO RC, Brenner EJ, Agrawal M, Zhang X, et al
    Impact of Medications on COVID-19 Outcomes in Inflammatory Bowel Disease: Analysis of Over 6,000 Patients from an International Registry.
    Gastroenterology. 2021 Sep 13. pii: S0016-5085(21)03490.

  122. ALLIN KH, Moayyedi P
    Proton pump inhibitor use - a risk factor for inflammatory bowel disease or an innocent bystander?
    Gastroenterology. 2021 Sep 6. pii: S0016-5085(21)03478.

  123. VAN DE GUCHTE M, Mondot S, Dore J
    Dynamic properties of the intestinal ecosystem call for combination therapies, targeting inflammation and microbiota, in ulcerative colitis.
    Gastroenterology. 2021 Sep 6. pii: S0016-5085(21)03482.
    PubMed     Abstract available

  124. ARGMANN C, Tokuyama M, Ungaro RC, Huang R, et al
    Molecular characterization of limited ulcerative colitis reveals novel biology and predictors of disease extension.
    Gastroenterology. 2021 Sep 1. pii: S0016-5085(21)03472.
    PubMed     Abstract available

  125. TURNER D, Hanauer SB
    Which Diet for Crohn's Disease? Food for Thought on the Specific Carbohydrate Diet, Mediterranean Diet, and Beyond.
    Gastroenterology. 2021;161:798-800.

    Quantification of Digestive Disease Damage in Crohn's Disease, Are We There Yet With the Lemann Index?
    Gastroenterology. 2021;161:800-802.

  127. PONSIOEN CY, de Jonge WJ
    Feeding the Gut-Liver Axis in PSC: What Makes It Different from IBD?
    Gastroenterology. 2021;161:1070-1071.

  128. SOFFER S, Kopylov U, Klang E
    Artificial Intelligence for the Evaluation of Mucosal Healing in IBD: The Future is Here.
    Gastroenterology. 2021;161:1073-1074.

  129. MURTHY SK, Feuerstein JD, Nguyen GC, Velayos FS, et al
    AGA Clinical Practice Update on Endoscopic Surveillance and Management of Colorectal Dysplasia in Inflammatory Bowel Diseases: Expert Review.
    Gastroenterology. 2021;161:1043-1051.
    PubMed     Abstract available

  130. LEWIS JD, Sandler RS, Brotherton C, Brensinger C, et al
    A Randomized Trial Comparing the Specific Carbohydrate Diet to a Mediterranean Diet in Adults With Crohn's Disease.
    Gastroenterology. 2021;161:837-852.
    PubMed     Abstract available

  131. PARIENTE B, Torres J, Burisch J, Arebi N, et al
    Validation and Update of the Lemann Index to Measure Cumulative Structural Bowel Damage in Crohn's Disease.
    Gastroenterology. 2021;161:853-864.
    PubMed     Abstract available

  132. LE PH, Kuo CJ, Wu RC
    Colonic Bluish-Black Patches in a 57-Year-Old Woman with Crohn's Disease.
    Gastroenterology. 2021;161:e10-e11.

    August 2021
  133. SANDBORN W, Mattheakis LC, Modi NB, Pugatch D, et al
    PTG-100, an Oral alpha4beta7 Antagonist Peptide: Preclinical Development and Phase 1 and 2a Studies in Ulcerative Colitis.
    Gastroenterology. 2021 Aug 30. pii: S0016-5085(21)03463.
    PubMed     Abstract available

  134. BARBERIO B, Massimi D, Cazzagon N, Zingone F, et al
    Prevalence of Primary Sclerosing Cholangitis in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    Gastroenterology. 2021 Aug 20. pii: S0016-5085(21)03412.
    PubMed     Abstract available

  135. POZDNYAKOVA V, Botwin GJ, Sobhani K, Prostko J, et al
    Decreased Antibody Responses to Ad26.COV2.S Relative to SARS-CoV-2 mRNA Vaccines in Patients with Inflammatory Bowel Disease.
    Gastroenterology. 2021 Aug 12. pii: S0016-5085(21)03360.

  136. KUWADA T, Shiokawa M, Seno H
    Two novel autoantibodies in patients with ulcerative colitis.
    Gastroenterology. 2021 Aug 10. pii: S0016-5085(21)03354.

  137. XIA B, Yang M, Nguyen LH, He Q, et al
    Regular use of proton pump inhibitor and the risk of inflammatory bowel disease: pooled analysis of three prospective cohorts.
    Gastroenterology. 2021 Aug 10. pii: S0016-5085(21)03350.
    PubMed     Abstract available

  138. ROGLER G, Singh A, Kavanaugh A, Rubin DT, et al
    Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management.
    Gastroenterology. 2021 Aug 3. pii: S0016-5085(21)03337.
    PubMed     Abstract available

  139. JONES JL, Tse F, Carroll MW, deBruyn JC, et al
    Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 2: Inactivated Vaccines.
    Gastroenterology. 2021;161:681-700.
    PubMed     Abstract available

  140. WONG SY, Dixon R, Martinez Pazos V, Gnjatic S, et al
    Serologic Response to Messenger RNA Coronavirus Disease 2019 Vaccines in Inflammatory Bowel Disease Patients Receiving Biologic Therapies.
    Gastroenterology. 2021;161:715-718.

  141. SARTOR RB
    Targeting Adaptive Immune Responses to Human Bacterial Flagellins in Crohn's Disease.
    Gastroenterology. 2021;161:416-418.

  142. DUBINSKY MC, Collins R, Abreu MT
    Challenges and Opportunities in IBD Clinical Trial Design.
    Gastroenterology. 2021;161:400-404.

  143. ALEXANDER KL, Zhao Q, Reif M, Rosenberg AF, et al
    Human Microbiota Flagellins Drive Adaptive Immune Responses in Crohn's Disease.
    Gastroenterology. 2021;161:522-535.
    PubMed     Abstract available

  144. FURFARO F, Solitano V, Danese S
    An Unusual Case of Cardiac Involvement in Crohn's Disease.
    Gastroenterology. 2021;161:431-433.

    July 2021
  145. BERGEMALM D, Andersson E, Hultdin J, Eriksson C, et al
    Systemic inflammation in pre-clinical ulcerative colitis.
    Gastroenterology. 2021 Jul 20. pii: S0016-5085(21)03277.
    PubMed     Abstract available

  146. MEDERACKE I, Wiestler M, Wedemeyer H
    An unusual cause of erythema on both lower legs in a patient with Crohn s disease.
    Gastroenterology. 2021 Jul 16. pii: S0016-5085(21)03249.

  147. LECHNER K, Mott S, Al-Saifi R, Knipfer L, et al
    Targeting of the Tec kinase ITK drives resolution of T cell-mediated colitis and emerges as potential therapeutic option in ulcerative colitis.
    Gastroenterology. 2021 Jul 3. pii: S0016-5085(21)03186.
    PubMed     Abstract available

  148. BEN-TOV A, Banon T, Chodick G, Kariv R, et al
    BNT162b2 mRNA COVID-19 Vaccine Effectiveness in Patients with Inflammatory Bowel Disease: Preliminary Real World Data during Mass Vaccination Campaign.
    Gastroenterology. 2021 Jul 2. pii: S0016-5085(21)03233.

  149. PAPA A, Gasbarrini A, Lopetuso LR
    Winter Is Coming and COVID-19 Vaccine Is Available! The Role of Gastroenterologist in Increasing COVID-19 Vaccine Acceptability Among IBD Patients.
    Gastroenterology. 2021;161:368-369.

  150. RODRIGUEZ-PALACIOS A, Basson AR, Cominelli F
    Artificial Sweeteners and Whole-Food Science: Could Mice Help Clinicians Make Diet Recommendations for IBD Patients?
    Gastroenterology. 2021;161:8-14.

  151. DE A, Chen W, Li H, Wright JR, et al
    Bacterial Swarmers Enriched During Intestinal Stress Ameliorate Damage.
    Gastroenterology. 2021;161:211-224.
    PubMed     Abstract available

    June 2021
  152. TAKADA Y, Ishikawa T, Kawashima H
    An unusual pancreatic mass with ductal disruption: benign or malignant?
    Gastroenterology. 2021 Jun 26. pii: S0016-5085(21)03173.

    PEG and mucosal biofilms in irritable bowel syndrome and ulcerative colitis.
    Gastroenterology. 2021 Jun 24. pii: S0016-5085(21)03167.

  154. BAUMGARTNER M, Lang M, Holley H, Crepaz D, et al
    Mucosal biofilms are an endoscopic feature of irritable bowel syndrome and ulcerative colitis.
    Gastroenterology. 2021 Jun 16. pii: S0016-5085(21)03138.
    PubMed     Abstract available

  155. PEYRIN-BIROULET L, Loftus EV Jr, Colombel JF, Danese S, et al
    Histologic Outcomes With Vedolizumab Versus Adalimumab in Ulcerative Colitis: Results From VARSITY.
    Gastroenterology. 2021 Jun 15. pii: S0016-5085(21)03126.
    PubMed     Abstract available

  156. HADI YB, Thakkar S, Shah-Khan SM, Hutson W, et al
    COVID-19 vaccination is safe and effective in patients with inflammatory bowel disease: Analysis of a large multi-institutional research network in United States.
    Gastroenterology. 2021 Jun 15. pii: S0016-5085(21)03125.

  157. MAHMUD N, Weiss A, Trivedi C, Yang YX, et al
    Risk of Venous Thromboembolism among Inflammatory Bowel Disease patients who contract SARS-CoV-2.
    Gastroenterology. 2021 Jun 14. pii: S0016-5085(21)03123.

  158. NARULA N, Wong ECL, Dehghan M, Marshall JK, et al
    BRIEF COMMUNICATION: Does High Inflammatory Diet Increase Risk of Inflammatory Bowel Disease? Results from the Prospective Urban Rural Epidemiology (PURE) study: A Prospective Cohort Study.
    Gastroenterology. 2021 Jun 9. pii: S0016-5085(21)03096.

  159. BARBERIO B, Buda A, Savarino EV
    Should Patients With Inflammatory Bowel Disease Be Tested for Active COVID-19 Before Starting a Biological Treatment?
    Gastroenterology. 2021;160:2626-2627.

  160. BEZZIO C, Saibeni S
    Severe Inflammatory Bowel Disease Flares and COVID-19: Expand the Gastroenterology-Surgery Team to Include an Infectious Disease Specialist.
    Gastroenterology. 2021;160:2625-2626.

  161. MAGO S, Vaziri H, Tadros M
    The Usefulness of Fecal Calprotectin in the era of the COVID-19 Pandemic.
    Gastroenterology. 2021;160:2623-2625.

  162. PREIDIS GA, Su GL, Morgan RL
    Gastroenterology. 2021;160:2633-2635.

  163. STANGE EF, von Bunau R, Erhardt A
    Ulcerative colitis-Maintanance of Remission With the Probiotic Escherichia coli Strain Nissle 1917.
    Gastroenterology. 2021;160:2632.

  164. SHMIDT E, Ho EY, Feuerstein JD, Singh S, et al
    Spotlight: Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn's Disease.
    Gastroenterology. 2021;160:2511.

  165. HO EY, Singh S, Terdiman JP
    Providing the Best Care for Patients With Crohn's Disease: An Examination of the New AGA Clinical Practice Guidelines on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn's Disease.
    Gastroenterology. 2021;160:2557-2562.

  166. SINGH S, Proctor D, Scott FI, Falck-Ytter Y, et al
    AGA Technical Review on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn's Disease.
    Gastroenterology. 2021;160:2512-2556.
    PubMed     Abstract available

  167. Medical Management of Adult Outpatients With Moderate to Severe Lunminal Crohn's Disease: Clinical Decision Support Tool.
    Gastroenterology. 2021;160:2509-2510.

  168. FEUERSTEIN JD, Ho EY, Shmidt E, Singh H, et al
    AGA Clinical Practice Guidelines on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn's Disease.
    Gastroenterology. 2021;160:2496-2508.

  169. LORZADEH A, Romero-Wolf M, Goel A, Jadhav U, et al
    Epigenetic Regulation of Intestinal Stem Cells and Disease: A Balancing Act of DNA and Histone Methylation.
    Gastroenterology. 2021;160:2267-2282.
    PubMed     Abstract available

  170. LI X, Liang D, Meng J, Zhou J, et al
    Development and Validation of a Novel Computed-Tomography Enterography Radiomic Approach for Characterization of Intestinal Fibrosis in Crohn's Disease.
    Gastroenterology. 2021;160:2303-2316.
    PubMed     Abstract available

  171. EDELMAN-KLAPPER H, Schwartz E, Ben-Horin S
    Visible Worms in a Crohn's Patient Treated with Infliximab.
    Gastroenterology. 2021;160:e10-e11.

    May 2021
  172. KHAN N, Mahmud N
    Effectiveness of SARS-CoV-2 vaccination in a Veterans Affairs Cohort of Inflammatory Bowel Disease Patients with Diverse Exposure to Immunosuppressive Medications.
    Gastroenterology. 2021 May 25. pii: S0016-5085(21)03066.
    PubMed     Abstract available

  173. PAI N, Popov J, Hill L, Hartung E, et al
    Results of the first pilot randomized controlled trial of fecal microbiota transplant in pediatric ulcerative colitis: lessons, limitations, and future prospects.
    Gastroenterology. 2021 May 4. pii: S0016-5085(21)00739.

  174. STALGIS C, Deepak P, Mehandru S, Colombel JF, et al
    Rational Combination Therapy to Overcome the Plateau of Drug Efficacy in Inflammatory Bowel Disease.
    Gastroenterology. 2021 May 4. pii: S0016-5085(21)00740.

  175. OCCHIPINTI V, Saibeni S, Sampietro GM, Pastorelli L, et al
    Impact of COVID-19 Outbreak on the Management of Patients With Severe IBD: A Domino Effect.
    Gastroenterology. 2021;160:2196-2197.

  176. SAHA S, Mara K, Pardi DS, Khanna S, et al
    Long-term Safety of Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection.
    Gastroenterology. 2021;160:1961-1969.
    PubMed     Abstract available

    April 2021
  177. AGRAWAL M, Spencer EA, Colombel JF, Ungaro RC, et al
    Approach to the management of recently diagnosed inflammatory bowel disease patients: a user's guide for adult and pediatric gastroenterologists.
    Gastroenterology. 2021 Apr 30. pii: S0016-5085(21)00734.
    PubMed     Abstract available

  178. RAJAMAKI K, Taira A, Katainen R, Valimaki N, et al
    Genetic and epigenetic characteristics of inflammatory bowel disease associated colorectal cancer.
    Gastroenterology. 2021 Apr 27. pii: S0016-5085(21)00680.
    PubMed     Abstract available

  179. AGRAWAL M, Hillenbrand CM, Allin KH, Torres J, et al
    Early life greenspace and the risk of pediatric-onset inflammatory bowel disease: insights into the link between environmental and human health.
    Gastroenterology. 2021 Apr 15. pii: S0016-5085(21)00644.

  180. SHEEHAN JL, Brandler J, Rice MD
    A Case of Recurrent Hepatic Abscesses.
    Gastroenterology. 2021 Apr 8. pii: S0016-5085(21)00627.

  181. TAXONERA C, Alba C, Olivares D
    What Is the Incidence of COVID-19 in Patients With IBD in Western Countries?
    Gastroenterology. 2021;160:1901-1902.

  182. MAGRO F, Dias CC, Morato M
    Aminosalicylates and COVID-19: Facts or Coincidences?
    Gastroenterology. 2021;160:1884-1885.

  183. RODRIGUEZ-LAGO I, Alonso-Galan H, Cabriada JL
    Cytokine Storm in IBD: Balancing the Risks of IBD Medical Therapy.
    Gastroenterology. 2021;160:1878-1880.

  184. RABINOWITZ LG, Kim MK, Wong SY
    Farnesoid X Receptor Variant: A Sex-based Determinant of Crohn's Disease Progression.
    Gastroenterology. 2021;160:1866-1867.

  185. SHORT SP, Pilat JM, Barrett CW, Reddy VK, et al
    Colonic Epithelial-Derived Selenoprotein P Is the Source for Antioxidant-Mediated Protection in Colitis-Associated Cancer.
    Gastroenterology. 2021;160:1694-1708.
    PubMed     Abstract available

  186. GETTLER K, Levantovsky R, Moscati A, Giri M, et al
    Common and Rare Variant Prediction and Penetrance of IBD in a Large, Multi-ethnic, Health System-based Biobank Cohort.
    Gastroenterology. 2021;160:1546-1557.
    PubMed     Abstract available

  187. QU JY, Li Z
    Is It a Crohn's Disease?
    Gastroenterology. 2021;160:1477-1478.

    March 2021
  188. SOLITANO V, Vuitton L, Peyrin-Biroulet L, Danese S, et al
    The Evolution of Biologics Administration From Intravenous to Subcutaneous: Treatments for Inflammatory Bowel Disease Goes Home.
    Gastroenterology. 2021 Mar 24. pii: S0016-5085(21)00548.

  189. SHIRAI T, Kakuta Y, Fujii H
    Distinct autoantibodies against endothelial protein C receptor in ulcerative colitis.
    Gastroenterology. 2021 Mar 24. pii: S0016-5085(21)00547.

  190. UNGER LW, Kaser A
    Is IL-6 back in trans signalling for inflammatory bowel disease?
    Gastroenterology. 2021 Mar 19. pii: S0016-5085(21)00539.

  191. SCHREIBER S, Ben-Horin S, Leszczyszyn J, Dudkowiak R, et al
    Randomized Controlled Trial: Subcutaneous versus Intravenous Infliximab CT-P13 Maintenance in Inflammatory Bowel Disease.
    Gastroenterology. 2021 Mar 4. pii: S0016-5085(21)00474.
    PubMed     Abstract available

  192. SCHREIBER S, Aden K, Bernardes JP, Conrad C, et al
    Therapeutic IL-6 trans-signalling inhibition by olamkicept (sgp130Fc) in patients with active inflammatory bowel disease.
    Gastroenterology. 2021 Mar 2. pii: S0016-5085(21)00467.
    PubMed     Abstract available

  193. VERMEIRE S, Hebuterne X, Tilg H, De Hertogh G, et al
    Induction and long-term follow-up with ABX464 for moderate-to-severe ulcerative colitis: Results of phase 2a trial.
    Gastroenterology. 2021 Mar 1. pii: S0016-5085(21)00459.

  194. ILIEV ID, Cadwell K
    Effects of Intestinal Fungi and Viruses on Immune Responses and Inflammatory Bowel Diseases.
    Gastroenterology. 2021;160:1050-1066.
    PubMed     Abstract available

  195. LU R, Zhang YG, Xia Y, Zhang J, et al
    Paneth Cell Alertness to Pathogens Maintained by Vitamin D Receptors.
    Gastroenterology. 2021;160:1269-1283.
    PubMed     Abstract available

  196. KUMAR A, Priyamvada S, Ge Y, Jayawardena D, et al
    A Novel Role of SLC26A3 in the Maintenance of Intestinal Epithelial Barrier Integrity.
    Gastroenterology. 2021;160:1240-1255.
    PubMed     Abstract available

  197. AL-BAHLANI AQ, Kron CM, Hart L
    Chronic Diarrhea in a Pediatric Patient after Bone Marrow Transplantation.
    Gastroenterology. 2021;160:e10-e12.

    February 2021
  198. BENCHIMOL EI, Tse F, Carroll MW, deBruyn JC, et al
    TEMPORARY REMOVAL: Canadian Association of Gastroenterology CLINICAL Practice Guideline For Immunizations in Patients with Inflammatory Bowel Disease (IBD). Part 2: Inactivated Vaccines.
    Gastroenterology. 2021 Feb 19. pii: S0016-5085(21)00427.
    PubMed     Abstract available

  199. MA C, Sedano R, Almradi A, Casteele NV, et al
    An international consensus to standardize integration of histopathology in ulcerative colitis clinical trials.
    Gastroenterology. 2021 Feb 18. pii: S0016-5085(21)00423.
    PubMed     Abstract available

  200. KUWADA T, Shiokawa M, Kodama Y, Ota S, et al
    Identification of an Anti-Integrin alphavbeta6 Autoantibody in Patients with Ulcerative Colitis.
    Gastroenterology. 2021 Feb 11. pii: S0016-5085(21)00406.
    PubMed     Abstract available

  201. COHEN RD, Feuerstein JD, Rubin DT
    REPLY to letters to the editor regarding manuscript Rubin DT, Feuerstein JD, Wang AY, Cohen RD, AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary, Gastroenterology (2020).
    Gastroenterology. 2021 Feb 6. pii: S0016-5085(21)00399.

  202. NOWAK JK, Kalla R, Satsangi J
    SARS-CoV-2 entry molecules' expression and COVID-19 in inflammatory bowel disease: is the gut critical?
    Gastroenterology. 2021 Feb 4. pii: S0016-5085(21)00350.

  203. KHANNA R, Afif W
    Ustekinumab for Ulcerative colitis.
    Gastroenterology. 2021 Feb 3. pii: S0016-5085(21)00340.

  204. POTDAR AA, Dube S, Naito T, Li K, et al
    Altered Intestinal ACE2 Levels Are Associated With Inflammation, Severe Disease, and Response to Anti-Cytokine Therapy in Inflammatory Bowel Disease.
    Gastroenterology. 2021;160:809-822.
    PubMed     Abstract available

  205. TE GROEN M, Derks MEW, Kuijpers CCHJ, Nagtegaal ID, et al
    Reduction in Inflammatory Bowel Disease Healthcare During the Coronavirus Disease 2019 Pandemic: A Nationwide Retrospective Cohort Study.
    Gastroenterology. 2021;160:935-937.

  206. PATANKAR JV, Chiriac MT, Lehmann M, Kuhl AA, et al
    Severe Acute Respiratory Syndrome Coronavirus 2 Attachment Receptor Angiotensin-Converting Enzyme 2 Is Decreased in Crohn's Disease and Regulated By Microbial and Inflammatory Signaling.
    Gastroenterology. 2021;160:925-928.

  207. MELMED GY, Rubin DT, McGovern DPB
    Winter Is Coming! Clinical, Immunologic, and Practical Considerations for Vaccinating Patients With Inflammatory Bowel Disease During the Coronavirus Disease-2019 Pandemic.
    Gastroenterology. 2021;160:639-644.

  208. BURGUENO JF, Fritsch J, Gonzalez EE, Landau KS, et al
    Epithelial TLR4 Signaling Activates DUOX2 to Induce Microbiota-Driven Tumorigenesis.
    Gastroenterology. 2021;160:797-808.
    PubMed     Abstract available

  209. BARNES EL, Loftus EV Jr, Kappelman MD
    Effects of Race and Ethnicity on Diagnosis and Management of Inflammatory Bowel Diseases.
    Gastroenterology. 2021;160:677-689.
    PubMed     Abstract available

  210. CHUNG-YEE HUI R, Kuo KL, Yang TW
    A Rare Skin Complication Associated With Crohn's Disease.
    Gastroenterology. 2021;160:669-670.

  211. KUMAR A, Magro C, Lukin DJ
    Scattered Skin Eruptions in a Patient With Inflammatory Bowel Disease.
    Gastroenterology. 2021;160:e3-e5.

    January 2021
  212. ZILBAUER M, Heuschkel R
    Reply to Lee et al.: Analytical Mistakes Confound Attempted Validation: A Response to "Transcription and DNA Methylation Patterns of Blood-Derived CD8+ T Cells Are Associated With Age and Inflammatory Bowel Disease But Do Not Predict Prognosis".
    Gastroenterology. 2021 Jan 25. pii: S0016-5085(21)00317.

  213. MESERVE J, Singh S
    Pathologist, meet Picasso! Virtual chromoendoscopy for detecting histologic remission in ulcerative colitis.
    Gastroenterology. 2021 Jan 25. pii: S0016-5085(21)00318.

  214. TAKENAKA K, Ohtsuka K, Fujii T, Oshima S, et al
    Deep neural network accurately predicts prognosis of ulcerative colitis using endoscopic images.
    Gastroenterology. 2021 Jan 21. pii: S0016-5085(21)00278.

  215. RANDOLPH GJ, Czepielewski RS
    Response to: Lymphatic-dependent transport of chylomicrons in inflammatory bowel disease.
    Gastroenterology. 2021 Jan 20. pii: S0016-5085(21)00270.

  216. PINTO-SANCHEZ MI, Seiler C, Verdu EF
    Reply to: Inflammatory bowel disease, celiac disease, and primary sclerosing cholangitis: is there a link?
    Gastroenterology. 2021 Jan 20. pii: S0016-5085(21)00273.

  217. BRAND EC, Klaassen MAY, Gacesa R, Vila AV, et al
    Healthy cotwins share gut microbiome signatures with their inflammatory bowel disease twins and unrelated patients.
    Gastroenterology. 2021 Jan 18. pii: S0016-5085(21)00097.
    PubMed     Abstract available

  218. BHAT S, Farraye FA, Hayney MS, Caldera F, et al
    How to Implement a Successful Vaccination Program in Outpatient Gastroenterology Practices: A Focus on Patients with Inflammatory Bowel Disease and Chronic Liver Disease.
    Gastroenterology. 2021 Jan 15. pii: S0016-5085(21)00093.

  219. KHAN N, Yang YX
    Adherence of Infusible Biologics During the Time of COVID-19 Among Patients with Inflammatory Bowel Disease: A Nationwide Veterans Affairs Cohort Study.
    Gastroenterology. 2021 Jan 13. pii: S0016-5085(21)00071.

  220. LEE JC, Lyons PA, McKinney EF
    Analytical Mistakes Confound Attempted Validation: A Response to "Transcription and DNA Methylation Patterns of Blood-Derived CD8+ T Cells Are Associated With Age and Inflammatory Bowel Disease But Do Not Predict Prognosis".
    Gastroenterology. 2021 Jan 13. pii: S0016-5085(21)00081.

  221. LE BERRE C, Peyrin-Biroulet L
    Selecting Endpoints for Disease-Modification Trials in Inflammatory Bowel Disease: the SPIRIT consensus from the IOIBD.
    Gastroenterology. 2021 Jan 6. pii: S0016-5085(21)00016.
    PubMed     Abstract available

  222. CHEN E, Chuang LS, Giri M, Villaverde N, et al
    Inflamed ulcerative colitis regions associated to MRGPRX2-mediated mast cell degranulation and cell activation modules, defining a new therapeutic target.
    Gastroenterology. 2021 Jan 6. pii: S0016-5085(21)00024.
    PubMed     Abstract available

  223. SUAREZ-FARINAS M, Tokuyama M, Wei G, Huang R, et al
    Intestinal Inflammation Modulates the Expression of ACE2 and TMPRSS2 and Potentially Overlaps With the Pathogenesis of SARS-CoV-2-related Disease.
    Gastroenterology. 2021;160:287-301.
    PubMed     Abstract available

  224. LEE M, Chang EB
    Inflammatory Bowel Diseases (IBD) and the Microbiome-Searching the Crime Scene for Clues.
    Gastroenterology. 2021;160:524-537.
    PubMed     Abstract available

  225. KELLERMAYER R, van der Laan M
    Validation of Predictive Models in Inflammatory Bowel Diseases.
    Gastroenterology. 2021;160:21-22.

  226. NORSA L, D'Antiga L
    Gastroenterology. 2021;160:474-475.

  227. SAZONOVS A, Ahmad T, Anderson CA
    Underpowered PANTS: A Response to the Conclusions of "Extended Analysis Identifies Drug-Specific Association of Two Distinct HLA Class II Haplotypes for Development of Immunogenicity to Adalimumab and Infliximab".
    Gastroenterology. 2021;160:470-471.

  228. CASADEI C, Barberio B, Savarino E
    A Peculiar Cutaneous Manifestation in a Patient With Crohn's Disease.
    Gastroenterology. 2021;160:e1-e3.

  229. ZHANG J, Hoedt EC, Liu Q, Berendsen E, et al
    Elucidation of Proteus mirabilis as a Key Bacterium in Crohn's Disease Inflammation.
    Gastroenterology. 2021;160:317-330.
    PubMed     Abstract available

  230. RICCIUTO A, Aardoom M, Orlanski-Meyer E, Navon D, et al
    Predicting Outcomes in Pediatric Crohn's Disease for Management Optimization: Systematic Review and Consensus Statements From the Pediatric Inflammatory Bowel Disease-Ahead Program.
    Gastroenterology. 2021;160:403-436.
    PubMed     Abstract available

    December 2020
  231. UNGARO RC, Kappelman MD, Rubin DT, Colombel JF, et al
    COVID-19 and Inflammatory Bowel Disease: Lessons Learned, Practical Recommendations, and Unanswered Questions.
    Gastroenterology. 2020 Dec 30. pii: S0016-5085(20)35600.

  232. TIAN Y, Zuo L
    Lymphatic-dependent transport of chylomicrons in inflammatory bowel disease.
    Gastroenterology. 2020 Dec 29. pii: S0016-5085(20)35599.

  233. TSE CS, Deepak P, Papadakis K
    Inflammatory bowel disease, celiac disease, and primary sclerosing cholangitis: is there a link?
    Gastroenterology. 2020 Dec 29. pii: S0016-5085(20)35594.

  234. WIJNANDS AM, de Jong ME, Lutgens MWMD, Hoentjen F, et al
    Prognostic factors for advanced colorectal neoplasia in inflammatory bowel disease: systematic review and meta-analysis.
    Gastroenterology. 2020 Dec 29. pii: S0016-5085(20)35587.
    PubMed     Abstract available

  235. SHIMIZU MS, Matsuo T, Mori N
    A rare manifestation associated with a urinary tract infection in a patient with ulcerative colitis.
    Gastroenterology. 2020 Dec 21. pii: S0016-5085(20)35566.

  236. TURNER D, Ricciuto A, Lewis A, D'Amico F, et al
    STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD.
    Gastroenterology. 2020 Dec 21. pii: S0016-5085(20)35572.
    PubMed     Abstract available

  237. DEVLIN JC, Axelrad J, Hine AM, Chang S, et al
    Single Cell Transcriptional Survey of Ileal-Anal Pouch Immune Cells from Ulcerative Colitis Patients.
    Gastroenterology. 2020 Dec 21. pii: S0016-5085(20)35571.
    PubMed     Abstract available

  238. IACUCCI M, Smith SC, Bazarova A, Shivaji UN, et al
    An international multicenter real-life prospective study of electronic chromoendoscopy score PICaSSO in Ulcerative Colitis.
    Gastroenterology. 2020 Dec 18. pii: S0016-5085(20)35563.
    PubMed     Abstract available

  239. WAUTERS L, Ceulemans M, Frings D, Lambaerts M, et al
    Proton pump inhibitors reduce duodenal eosinophilia, mast cells and permeability in patients with functional dyspepsia.
    Gastroenterology. 2020 Dec 17. pii: S0016-5085(20)35552.
    PubMed     Abstract available

  240. KIM ES, Tarassishin L, Eisele C, Barre A, et al
    Longitudinal Changes in Fecal Calprotectin Levels among Pregnant Women with and without Inflammatory Bowel Disease and Their Babies.
    Gastroenterology. 2020 Dec 8. pii: S0016-5085(20)35532.
    PubMed     Abstract available

  241. VERSTOCKT B, Torres J
    Point-of-care intestinal ultrasound: prime time for the management of ulcerative colitis?
    Gastroenterology. 2020 Dec 8. pii: S0016-5085(20)35541.

  242. GALIPEAU HJ, Caminero A, Turpin W, Bermudez-Brito M, et al
    Novel fecal biomarkers that precede clinical diagnosis of ulcerative colitis.
    Gastroenterology. 2020 Dec 8. pii: S0016-5085(20)35533.
    PubMed     Abstract available

  243. ROSEN MJ
    Could a Small Population of Epithelial Cells Get "Tuft" With Crohn's Disease?
    Gastroenterology. 2020;159:2025-2027.

  244. KONG L, Lloyd-Price J, Vatanen T, Seksik P, et al
    Linking Strain Engraftment in Fecal Microbiota Transplantation With Maintenance of Remission in Crohn's Disease.
    Gastroenterology. 2020;159:2193-2202.
    PubMed     Abstract available

  245. BANERJEE A, Herring CA, Chen B, Kim H, et al
    Succinate Produced by Intestinal Microbes Promotes Specification of Tuft Cells to Suppress Ileal Inflammation.
    Gastroenterology. 2020;159:2101-2115.
    PubMed     Abstract available

  246. TURPIN W, Lee SH, Raygoza Garay JA, Madsen KL, et al
    Increased Intestinal Permeability Is Associated With Later Development of Crohn's Disease.
    Gastroenterology. 2020;159:2092-2100.
    PubMed     Abstract available

  247. COURTET A, Lemale J, Carra MC
    Generalized Gingival Hyperplasia and Rectorrhagia in a 13-Year-Old Boy.
    Gastroenterology. 2020;159:2030-2033.

  248. ANGELINO G, Francalanci P, Tambucci R
    Terminal Ileum Thickening and Mucosal Ulcers in a Boy With Neurofibromatosis Type 1.
    Gastroenterology. 2020;159:e9-e11.

    November 2020
  249. MAHADEVAN U, Long MD, Kane SV, Roy A, et al
    Pregnancy and Neonatal Outcomes after Fetal Exposure To Biologics and Thiopurines among Women with Inflammatory Bowel Disease.
    Gastroenterology. 2020 Nov 20. pii: S0016-5085(20)35441.
    PubMed     Abstract available

  250. TAXONERA C, Fisac J, Alba C
    Can COVID-19 trigger de novo inflammatory bowel disease?
    Gastroenterology. 2020 Nov 19. pii: S0016-5085(20)35424.

  251. FAIRBRASS KM, Gracie DJ, Ford AC
    In the Face of Adversity: Is Resilience Training a New Target for Inflammatory Bowel Disease Therapy?
    Gastroenterology. 2020 Nov 19. pii: S0016-5085(20)35417.

  252. TORRES J, Riddle M, Colombel JF
    Answer to the letter by Rodriguez-Lago et al: Pre-inflammatory bowel disease: back to the future.
    Gastroenterology. 2020 Nov 4. pii: S0016-5085(20)35363.

  253. KOCHAR B, Ananthakrishnan AN
    Gastroenterology. 2020;159:1993-1994.

  254. ALLEGRETTI JR, Kelly CR, Grinspan A, Mullish BH, et al
    Outcomes of Fecal Microbiota Transplantation in Patients With Inflammatory Bowel Diseases and Recurrent Clostridioides difficile Infection.
    Gastroenterology. 2020;159:1982-1984.

  255. PARLATO M, Nian Q, Charbit-Henrion F, Ruemmele FM, et al
    Loss-of-Function Mutation in PTPN2 Causes Aberrant Activation of JAK Signaling Via STAT and Very Early Onset Intestinal Inflammation.
    Gastroenterology. 2020;159:1968-1971.

  256. HUANG LH, Deepak P, Ciorba MA, Mittendorfer B, et al
    Postprandial Chylomicron Output and Transport Through Intestinal Lymphatics Are Not Impaired in Active Crohn's Disease.
    Gastroenterology. 2020;159:1955-1957.

  257. SPALINGER MR, Sayoc-Becerra A, Santos AN, Shawki A, et al
    PTPN2 Regulates Interactions Between Macrophages and Intestinal Epithelial Cells to Promote Intestinal Barrier Function.
    Gastroenterology. 2020;159:1763-1777.
    PubMed     Abstract available

    October 2020
  258. NAITO T, Botwin GJ, Haritunians T, Li D, et al
    Prevalence and Effect of Genetic Risk of Thrombo-embolic Disease in Inflammatory Bowel Disease.
    Gastroenterology. 2020 Oct 19. pii: S0016-5085(20)35276.
    PubMed     Abstract available

  259. GOTTLIEB K, Requa J, Karnes W, Chandra Gudivada R, et al
    Central reading of ulcerative colitis clinical trial videos using neural networks.
    Gastroenterology. 2020 Oct 17. pii: S0016-5085(20)35283.
    PubMed     Abstract available

  260. BOSSUYT P, De Hertogh G, Eelbode T, Vermeire S, et al
    Computer aided diagnosis with monochromatic light endoscopy for scoring histological remission in ulcerative colitis.
    Gastroenterology. 2020 Oct 12. pii: S0016-5085(20)35246.

  261. ANANTHAKRISHNAN AN, Nguyen GC, Bernstein CN
    AGA Clinical Practice Update on Management of Inflammatory Bowel Disease in the Elderly: Expert Review.
    Gastroenterology. 2020 Oct 1. pii: S0016-5085(20)35219.

  262. GARG M, Christensen B, Lubel JS
    Gastrointestinal ACE2, COVID-19 and IBD: Opportunity in the Face of Tragedy?
    Gastroenterology. 2020;159:1623-1624.

  263. PARIGI TL, Bonifacio C, Danese S
    Is It Crohn's Disease?
    Gastroenterology. 2020;159:1244-1246.

  264. TAKENAKA K, Ohtsuka K, Suzuki K, Watanabe M, et al
    Gastroenterology. 2020;159:1626-1627.

  265. GORDON M, Guyatt G
    Assessment of Evidence Quality in Inflammatory Bowel Disease Guidance: The Use and Misuse of GRADE.
    Gastroenterology. 2020;159:1209-1215.

  266. STENGEL ST, Fazio A, Lipinski S, Jahn MT, et al
    Activating Transcription Factor 6 Mediates Inflammatory Signals in Intestinal Epithelial Cells Upon Endoplasmic Reticulum Stress.
    Gastroenterology. 2020;159:1357-1374.
    PubMed     Abstract available

  267. RAWAT M, Nighot M, Al-Sadi R, Gupta Y, et al
    IL1B Increases Intestinal Tight Junction Permeability by Up-regulation of MIR200C-3p, Which Degrades Occludin mRNA.
    Gastroenterology. 2020;159:1375-1389.
    PubMed     Abstract available

    September 2020
  268. KELLY CR, Yen EF, Grinspan AM, Kahn SA, et al
    Fecal Microbiota Transplant is Highly Effective in Real-World Practice: Initial Results from the FMT National Registry.
    Gastroenterology. 2020 Sep 30. pii: S0016-5085(20)35221.
    PubMed     Abstract available

  269. MEYER EO, Aardoom M, Ricciuto A, Navon D, et al
    Predicting Outcomes in Pediatric Ulcerative Colitis for Management Optimization: Systematic Review and Consensus Statements from PIBD-Ahead Program.
    Gastroenterology. 2020 Sep 22. pii: S0016-5085(20)35206.
    PubMed     Abstract available

  270. PAUL S, Roblin X
    The Nightmare Monitoring of JAKinhibs.
    Gastroenterology. 2020;159:1188-1189.

  271. TILG H, D'Haens G
    How to Manage Crohn's Disease After Ileocolonic Resection?
    Gastroenterology. 2020;159:816-820.

  272. KANG JW, Yan J, Ranjan K, Zhang X, et al
    Myeloid Cell Expression of LACC1 Is Required for Bacterial Clearance and Control of Intestinal Inflammation.
    Gastroenterology. 2020;159:1051-1067.
    PubMed     Abstract available

  273. KREISS L, Thoma OM, Dilipkumar A, Carle B, et al
    Label-Free In Vivo Histopathology of Experimental Colitis via 3-Channel Multiphoton Endomicroscopy.
    Gastroenterology. 2020;159:832-834.

  274. HALL CHT, Lee JS, Murphy EM, Gerich ME, et al
    Creatine Transporter, Reduced in Colon Tissues From Patients With Inflammatory Bowel Diseases, Regulates Energy Balance in Intestinal Epithelial Cells, Epithelial Integrity, and Barrier Function.
    Gastroenterology. 2020;159:984-998.
    PubMed     Abstract available

  275. PINTO-SANCHEZ MI, Seiler CL, Santesso N, Alaedini A, et al
    Association Between Inflammatory Bowel Diseases and Celiac Disease: A Systematic Review and Meta-Analysis.
    Gastroenterology. 2020;159:884-903.
    PubMed     Abstract available

    August 2020
  276. STAHL E, Roda G, Dobbyn A, Hu J, et al
    Collagenous Colitis Is Associated With HLA Signature and Shares Genetic Risks With Other Immune-Mediated Diseases.
    Gastroenterology. 2020;159:549-561.
    PubMed     Abstract available

  277. POWELL DOHERTY RD, Liao H, Satsangi JJ, Ternette N, et al
    Extended Analysis Identifies Drug-Specific Association of 2 Distinct HLA Class II Haplotypes for Development of Immunogenicity to Adalimumab and Infliximab.
    Gastroenterology. 2020;159:784-787.

  278. APOSTOLOV R, Tan N, Vasudevan A
    Poor Bowel Preparation in Crohn's Disease.
    Gastroenterology. 2020;159:440-442.

    July 2020
    New Biomarkers for Crohn's Disease.
    Gastroenterology. 2020;159:30-32.

  280. UNO Y
    Why a Low FODMAP Diet Was Ineffective for IBS Symptoms in Quiescent Crohn's Disease.
    Gastroenterology. 2020;159:399.

  281. ARDALAN ZS, Sparrow M, Gibson PR
    The Importance of Accurate Phenotyping and Pouchitis Risk and Dietary Assessment When Investigating the Microbial Factors Behind Antibiotic-Dependent Pouchitis.
    Gastroenterology. 2020;159:399-400.

  282. PICKERT G, Wirtz S, Matzner J, Ashfaq-Khan M, et al
    Wheat Consumption Aggravates Colitis in Mice via Amylase Trypsin Inhibitor-mediated Dysbiosis.
    Gastroenterology. 2020;159:257-272.
    PubMed     Abstract available

  283. EL-MATARY W, Nugent Z, Bernstein CN, Singh H, et al
    Long-term Cancer Risk in Patients With Pediatric-Onset Inflammatory Bowel Diseases in the Canadian Population.
    Gastroenterology. 2020;159:386-387.

  284. NAIR N, Austin C, Curtin P, Gouveia C, et al
    Association Between Early-life Exposures and Inflammatory Bowel Diseases, Based on Analyses of Deciduous Teeth.
    Gastroenterology. 2020;159:383-385.

  285. UNGARO RC, Yzet C, Bossuyt P, Baert FJ, et al
    Deep Remission at 1 Year Prevents Progression of Early Crohn's Disease.
    Gastroenterology. 2020;159:139-147.
    PubMed     Abstract available

  286. MULLIN GE, Chey WD, Crowe SE
    The 2019 James W. Freston Conference: Food at the Intersection of Gut Health and Disease.
    Gastroenterology. 2020;159:20-25.

  287. HEALY ME, Boege Y, Hodder MC, Bohm F, et al
    MCL1 Is Required for Maintenance of Intestinal Homeostasis and Prevention of Carcinogenesis in Mice.
    Gastroenterology. 2020;159:183-199.
    PubMed     Abstract available

  288. TORRES J, Petralia F, Sato T, Wang P, et al
    Serum Biomarkers Identify Patients Who Will Develop Inflammatory Bowel Diseases Up to 5 Years Before Diagnosis.
    Gastroenterology. 2020;159:96-104.
    PubMed     Abstract available

    June 2020
  289. SABINO J, Torres J
    You Are What You Eat, But Can Diet Prevent Inflammatory Bowel Diseases?
    Gastroenterology. 2020;158:2304-2305.

  290. ZIDAR N
    Histopathology of Fibrosis in Crohn's Disease: The Importance of Understanding Its Pathogenesis.
    Gastroenterology. 2020;158:2313-2314.

  291. BOUHNIK Y, Louis E, Peyrin-Biroulet L
    Looking for Innovative Digital Solutions to Optimize Patient Recruitment in Inflammatory Bowel Disease Trials.
    Gastroenterology. 2020;158:2306-2307.

  292. KOLLEN L, Werner O, Gavotto A
    Uncommon Cause of Chest Pain in a 9-Year-Old Boy With Crohn's Disease.
    Gastroenterology. 2020;158:2055-2057.

  293. KOCHAR B, Cai W, Cagan A, Ananthakrishnan AN, et al
    Pretreatment Frailty Is Independently Associated With Increased Risk of Infections After Immunosuppression in Patients With Inflammatory Bowel Diseases.
    Gastroenterology. 2020;158:2104-2111.
    PubMed     Abstract available

  294. CROWLEY E, Warner N, Pan J, Khalouei S, et al
    Prevalence and Clinical Features of Inflammatory Bowel Diseases Associated With Monogenic Variants, Identified by Whole-Exome Sequencing in 1000 Children at a Single Center.
    Gastroenterology. 2020;158:2208-2220.
    PubMed     Abstract available

  295. SANDBORN WJ, Feagan BG, Loftus EV Jr, Peyrin-Biroulet L, et al
    Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn's Disease.
    Gastroenterology. 2020;158:2123-2138.
    PubMed     Abstract available

  296. LOEBENSTEIN M, Schulberg JD
    Anti-TNF Rechallenge After Infliximab Induced Lupus in Crohn's Disease.
    Gastroenterology. 2020;158:2069-2071.

    May 2020
  297. TRIVEDI PJ, Crothers H, Mytton J, Bosch S, et al
    Effects of Primary Sclerosing Cholangitis on Risks of Cancer and Death in People With Inflammatory Bowel Diseases, Based on Sex, Race, and Age.
    Gastroenterology. 2020 May 20. pii: S0016-5085(20)34702.
    PubMed     Abstract available

  298. OLIVERA PA, Lasa JS, Bonovas S, Danese S, et al
    Safety of Janus Kinase Inhibitors in Patients With Inflammatory Bowel Diseases or Other Immune-mediated Diseases: A Systematic Review and Meta-Analysis.
    Gastroenterology. 2020;158:1554-1573.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.